...
首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft.
【24h】

Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft.

机译:插入TIPS后难治性肝性脑病的治疗:使用沙漏形球囊扩张式支架移植物减少分流的长期结果。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The purpose of this study was to review the use of an hourglass-shaped expanded polytetrafluoroethylene (ePTFE) stent-graft to reduce transjugular intrahepatic portosystemic shunts in patients with hepatic encephalopathy refractory to conventional medical therapy. MATERIALS AND METHODS: From January 2000 through December 2008, 189 transjugular intrahepatic portosystemic shunt procedures were performed with self-expanding stent-grafts. After a mean period of 43.4 +/- 57 weeks, hepatic encephalopathy developed in 12 patients and did not respond to conventional medical therapy with lactulose, nonabsorbable antibiotics, and a protein-restricted diet. In all cases, shunt reduction was performed with an hourglass-shaped balloon-expandable ePTFE stent-graft inserted into the original shunt. RESULTS: Technically successful shunt reduction with an immediate increase in portosystemic gradient was achieved in all patients. Symptoms of hepatic encephalopathy disappeared a mean of 22.3 hours (range, 18-26 hours) after the procedure. After a mean follow-up period of 73.9 +/- 61.88 weeks, no recurrence of hepatic encephalopathy was found. One patient (8.3%) needed dilation of the hourglass-shaped stent-graft after 37 weeks because of recurrence of ascites. At the end of the study, five patients (41.6%) were alive in good clinical condition. Four patients (33.3%) died of cardiovascular failure 1, 2, 24, and 96 weeks after the corrective procedure. Eight months after the reduction procedure, one patient (8.3%) underwent orthotopic liver transplantation, which resulted in clinical improvement. Two patients (16.6%) were lost to follow-up 15.6 and 46.8 weeks after the procedure. CONCLUSION: Shunt reduction with an hourglass-shaped ePTFE balloon-expandable stent-graft seems effective in reducing shunt flow and rapidly improving the patient's clinical condition. With this technique, shunt diameter can be modified on the basis of the patient's clinical condition.
机译:目的:本研究的目的是回顾使用沙漏形的膨胀聚四氟乙烯(ePTFE)支架移植物,以减少传统医学治疗难以治疗的肝性脑病患者的经颈静脉肝内门体分流。材料与方法:自2000年1月至2008年12月,采用自扩张支架移植物进行了189例经颈静脉肝内门体分流术。平均43.4 +/- 57周后,有12例患者发展为肝性脑病,对乳果糖,不可吸收的抗生素和蛋白质限制饮食的常规药物治疗无反应。在所有情况下,均通过将沙漏形的球囊扩张型ePTFE支架移植物插入原始分流管中来减少分流管。结果:所有患者均实现了技术上成功的分流减少和门体系统梯度立即增加。手术后平均22.3小时(范围18-26小时),肝性脑病的症状消失。在平均73.9 +/- 61.88周的随访期后,未发现肝性脑病复发。 1名患者(8.3%)由于腹水复发,需要在37周后扩张沙漏形支架。在研究结束时,有5名患者(41.6%)处于良好的临床状态。在矫正手术后1、2、24和96周,有4名患者(33.3%)死于心血管衰竭。复位手术后八个月,一名患者(8.3%)接受了原位肝移植,从而改善了临床状况。术后15.6和46.8周有2例患者(16.6%)失访。结论:使用沙漏形ePTFE球囊扩张式支架移植物减少分流似乎可以有效减少分流并快速改善患者的临床状况。使用这种技术,可以根据患者的临床状况修改分流管直径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号